The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases von Baldwin, Susan L, Larsen, Sasha E, Ordway, Diane, Cassell, Gail, Coler, Rhea N

Volltext

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report von Jackson, Lisa A, Anderson, Evan J, Rouphael, Nadine G, Roberts, Paul C, Makhene, Mamodikoe, Coler, Rhea N, McCullough, Michele P, Chappell, James D, Denison, Mark R, Stevens, Laura J, Pruijssers, Andrea J, McDermott, Adrian, Flach, Britta, Doria-Rose, Nicole A, Corbett, Kizzmekia S, Morabito, Kaitlyn M, O’Dell, Sijy, Schmidt, Stephen D, Swanson, Phillip A, Padilla, Marcelino, Mascola, John R, Neuzil, Kathleen M, Bennett, Hamilton, Sun, Wellington, Peters, Etza, Makowski, Mat, Albert, Jim, Cross, Kaitlyn, Buchanan, Wendy, Pikaart-Tautges, Rhonda, Ledgerwood, Julie E, Graham, Barney S, Beigel, John H

Volltext

Homologous and Heterologous Covid-19 Booster Vaccinations von Atmar, Robert L, Lyke, Kirsten E, Deming, Meagan E, Jackson, Lisa A, Branche, Angela R, El Sahly, Hana M, Rostad, Christina A, Martin, Judith M, Johnston, Christine, Rupp, Richard E, Mulligan, Mark J, Brady, Rebecca C, Frenck, Robert W, Bäcker, Martín, Kottkamp, Angelica C, Babu, Tara M, Rajakumar, Kumaravel, Edupuganti, Srilatha, Dobrzynski, David, Coler, Rhea N, Posavad, Christine M, Archer, Janet I, Crandon, Sonja, Nayak, Seema U, Szydlo, Daniel, Zemanek, Jillian A, Dominguez Islas, Clara P, Brown, Elizabeth R, Suthar, Mehul S, McElrath, M. Juliana, McDermott, Adrian B, O’Connell, Sarah E, Montefiori, David C, Eaton, Amanda, Neuzil, Kathleen M, Stephens, David S, Roberts, Paul C, Beigel, John H

Volltext

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant von Coler, Rhea N, Bertholet, Sylvie, Moutaftsi, Magdalini, Guderian, Jeff A, Windish, Hillarie Plessner, Baldwin, Susan L, Laughlin, Elsa M, Duthie, Malcolm S, Fox, Christopher B, Carter, Darrick, Friede, Martin, Vedvick, Thomas S, Reed, Steven G

Volltext

New horizons in adjuvants for vaccine development von Reed, Steven G, Bertholet, Sylvie, Coler, Rhea N, Friede, Martin

Volltext

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model von Baldwin, Susan L., Reese, Valerie A., Larsen, Sasha E., Beebe, Elyse, Guderian, Jeff, Orr, Mark T., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.

Volltext

Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis? von Larsen, Sasha E., Baldwin, Susan L., Coler, Rhea N.

Volltext

A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika von Erasmus, Jesse H., Khandhar, Amit P., Guderian, Jeff, Granger, Brian, Archer, Jacob, Archer, Michelle, Gage, Emily, Fuerte-Stone, Jasmine, Larson, Elise, Lin, Susan, Kramer, Ryan, Coler, Rhea N., Fox, Christopher B., Stinchcomb, Dan T., Reed, Steven G., Van Hoeven, Neal

Volltext

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens von Knudsen, Niels Peter H., Olsen, Anja, Buonsanti, Cecilia, Follmann, Frank, Zhang, Yuan, Coler, Rhea N., Fox, Christopher B., Meinke, Andreas, D´Oro, Ugo, Casini, Daniele, Bonci, Alessandra, Billeskov, Rolf, De Gregorio, Ennio, Rappuoli, Rino, Harandi, Ali M., Andersen, Peter, Agger, Else Marie

Volltext

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines von Coler, Rhea N, Baldwin, Susan L, Shaverdian, Narek, Bertholet, Sylvie, Reed, Steven J, Raman, Vanitha S, Lu, Xiuhua, DeVos, Joshua, Hancock, Kathy, Katz, Jacqueline M, Vedvick, Thomas S, Duthie, Malcolm S, Clegg, Christopher H, Van Hoeven, Neal, Reed, Steven G

Volltext

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction von Dubois Cauwelaert, Natasha, Desbien, Anthony L, Hudson, Thomas E, Pine, Samuel O, Reed, Steven G, Coler, Rhea N, Orr, Mark T

Volltext

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity von Larsen, Sasha E, Williams, Brittany D, Rais, Maham, Coler, Rhea N, Baldwin, Susan L

Volltext

A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93 von Orr, Mark T, Beebe, Elyse A, Hudson, Thomas E, Moon, James J, Fox, Christopher B, Reed, Steven G, Coler, Rhea N

Volltext

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant von Lyke, Kirsten E., Atmar, Robert L., Islas, Clara Dominguez, Posavad, Christine M., Szydlo, Daniel, PaulChourdhury, Rahul, Deming, Meagan E., Eaton, Amanda, Jackson, Lisa A., Branche, Angela R., El Sahly, Hana M., Rostad, Christina A., Martin, Judith M., Johnston, Christine, Rupp, Richard E., Mulligan, Mark J., Brady, Rebecca C., Frenck, Robert W., Bäcker, Martín, Kottkamp, Angelica C., Babu, Tara M., Rajakumar, Kumaravel, Edupuganti, Srilatha, Dobrzynski, David, Coler, Rhea N., Archer, Janet I., Crandon, Sonja, Zemanek, Jillian A., Brown, Elizabeth R., Neuzil, Kathleen M., Stephens, David S., Post, Diane J., Nayak, Seema U., Suthar, Mehul S., Roberts, Paul C., Beigel, John H., Montefiori, David C.

Volltext

Antibodies as key mediators of protection against Mycobacterium tuberculosis von Wang, Qixin, Nag, Deepika, Baldwin, Susan L, Coler, Rhea N, McNamara, Ryan P

Volltext

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis von Orr, Mark T., Fox, Christopher B., Baldwin, Susan L., Sivananthan, Sandra J., Lucas, Elyse, Lin, Susan, Phan, Tony, Moon, James J., Vedvick, Thomas S., Reed, Steven G., Coler, Rhea N.

Volltext

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research von Daniel-Wayman, Shelby, Abate, Getahun, Barber, Daniel L, Bermudez, Luiz E, Coler, Rhea N, Cynamon, Michael H, Daley, Charles L, Davidson, Rebecca M, Dick, Thomas, Floto, R Andres, Henkle, Emily, Holland, Steven M, Jackson, Mary, Lee, Richard E, Nuermberger, Eric L, Olivier, Kenneth N, Ordway, Diane J, Prevots, D Rebecca, Sacchettini, James C, Salfinger, Max, Sassetti, Christopher M, Sizemore, Christine F, Winthrop, Kevin L, Zelazny, Adrian M

Volltext

Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis von Cecílio, Pedro, Pérez-Cabezas, Begoña, Fernández, Laura, Moreno, Javier, Carrillo, Eugenia, Requena, José M, Fichera, Epifanio, Reed, Steven G, Coler, Rhea N, Kamhawi, Shaden, Oliveira, Fabiano, Valenzuela, Jesus G, Gradoni, Luigi, Glueck, Reinhard, Gupta, Gaurav, Cordeiro-da-Silva, Anabela

Volltext

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140 von Arias, Mauricio A, Van Roey, Griet A, Tregoning, John S, Moutaftsi, Magdalini, Coler, Rhea N, Windish, Hillarie P, Reed, Steven G, Carter, Darrick, Shattock, Robin J

Volltext

Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology von Dijkman, Karin, Coler, Rhea N, Joosten, Simone A

Volltext